No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment

Rheumatology
Sylvain MathieuMartin Soubrier

Abstract

The excess cardiac risk, found in RA has been attributed to biological inflammation. Effective control of inflammation may be of benefit in reducing cardiovascular risk in RA patients. The aim of this study is to investigate the effects of 24 and 52 weeks of rituximab treatment on arterial stiffness and cardiovascular risk factors. Arterial stiffness was measured by augmentation index (AIx) and pulse wave velocity (PWV), and other cardiovascular risk factors (lipid profile, blood pressure) were collected in active RA patients. Thirty-three patients, of whom 29 were females, with a mean age of 60.9 (12.0) years were included. Thirty patients had positive RFs, 27 had positive anti-CCP antibody and 93.9% (n = 31) were erosive. Nineteen patients were non-responders to anti-TNF-α treatments. After rituximab treatment, no change was observed in arterial stiffness, neither after 6 nor after 12 months [PWV 8.1 (3.1) m/s at baseline, 8.1 (2.8) at 6 months, 8.0 (2.7) at 1 year, P = 0.924; and AIx 30.4 (8.2)% at baseline, 28.6 (7.6) at 6 months, 29.4 (6.7) at 1 year, P = 0.216]. Total and low-density lipoprotein cholesterol levels increased significantly but high-density lipoprotein (HDL) and triglyceride levels were unchanged. The athero...Continue Reading

References

Nov 28, 2008·Arthritis and Rheumatism·J Antonio Aviña-ZubietaDiane Lacaille
Jan 20, 2009·Current Pharmaceutical Design·Kaisa M Mäki-Petäjä, Ian B Wilkinson
Jul 7, 2010·The Journal of Experimental Medicine·Hafid Ait-OufellaZiad Mallat

❮ Previous
Next ❯

Citations

Aug 30, 2014·BioMed Research International·Miodrag JanićMišo Sabovič
Oct 16, 2014·Current Rheumatology Reports·Debbie T LimTed R Mikuls
Dec 22, 2012·Expert Review of Clinical Immunology·Claudio Ponticelli
Dec 7, 2013·Expert Review of Clinical Immunology·Samuel Morris-RosenfeldColeen A McNamara
Jun 9, 2015·Translational Research : the Journal of Laboratory and Clinical Medicine·Jiayun ShenLai-Shan Tam
Jun 2, 2014·Joint, Bone, Spine : Revue Du Rhumatisme·Martin SoubrierSylvain Mathieu
Sep 25, 2015·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Catherine QuinlanKjell Tullus
Oct 16, 2013·Atherosclerosis·D F van Breukelen-van der StoepM Castro Cabezas
Jun 15, 2014·Clinical Rheumatology·Dimitrios VassilopoulosChristodoulos Stefanadis
Jan 11, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Michael NurmohamedPaola Accossato
Oct 11, 2016·Therapeutic Advances in Musculoskeletal Disease·Anne TournadreMartin Soubrier
Jul 19, 2014·World Journal of Orthopedics·Antongiulio ScarnoAntonio Spadaro
Feb 4, 2016·Journal of Korean Medical Science·Diana S NovikovaEvgeny L Nasonov
Jun 12, 2020·Rheumatology International·Aliki I VenetsanopoulouAlexandros A Drosos
Jan 9, 2019·Frontiers in Cardiovascular Medicine·Elena BartoloniRoberto Gerli
Jul 28, 2020·Joint, Bone, Spine : Revue Du Rhumatisme·Charlotte GiraudAnne Tournadre
Mar 7, 2021·Expert Review of Clinical Immunology·George A KarpouzasSarah R Ormseth
Apr 10, 2021·Nature Reviews. Rheumatology·Fabiola AtzeniZoltán Szekanecz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.